The drug is RI-AG03, and it's a peptide inhibitor (a blocker of proteins). In tests on fruit flies and human cells, it has ...
The increasing knowledge on how protein tau is organized in live cells has shown that the protein forms nanometer-sized ...
“This research is taking promising steps towards a new one-of-a-kind therapy which targets tau, a damaging protein in the ...
An international team of researchers led by Lancaster University has made a promising breakthrough in the development of ...
Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in ...
A peptide inhibitor called RI-AG03 targets major aggregation “hot spots” of tau proteins, believed to be a key driver of ...
An international team of researchers has made a significant breakthrough in Alzheimer's drug development with the ...
Now, an international team led by Lancaster University in the UK says it has developed a drug called RI-AG03 that targets and blocks the two “hot spots” where tau clumping tends to occur.
Scientists say they have achieved a "first" in the development of drugs to treat Alzheimer's disease. In a study published in the journal Alzheimer's & Dementia, a team of researchers report the ...